Homework answers / question archive / SUPPORTIVE SUBMISSION 1 Rationale       This study evaluated the effectiveness of a multifactorial intervention on improving the therapeutic adherence in chronic obstructive pulmonary disease (COPD) patients with scheduled inhalation therapy since previous studies have shown poor therapeutic adherence of COPD patients

SUPPORTIVE SUBMISSION 1 Rationale       This study evaluated the effectiveness of a multifactorial intervention on improving the therapeutic adherence in chronic obstructive pulmonary disease (COPD) patients with scheduled inhalation therapy since previous studies have shown poor therapeutic adherence of COPD patients

Writing

Share With

---

SUPPORTIVE SUBMISSION 1

Rationale

      This study evaluated the effectiveness of a multifactorial intervention on improving the therapeutic adherence in chronic obstructive pulmonary disease (COPD) patients with scheduled inhalation therapy since previous studies have shown poor therapeutic adherence of COPD patients.

      Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is a chronic and progressive disease that requires long-term management, and non-adherence to treatment is a major barrier to achieving optimal outcomes. This study addresses this gap in knowledge by evaluating the effectiveness of a multifactorial intervention on improving therapeutic adherence in patients with COPD. The intervention included education, inhaler technique training, and regular follow-up visits with a nurse. The study found that the multifactorial intervention was effective in improving therapeutic adherence, inhaler technique, and quality of life in patients with COPD. This study is important because it provides evidence-based interventions that can be implemented in clinical practice to improve therapeutic adherence and clinical outcomes in patients with COPD. The findings from this study can inform the development of guidelines and interventions to improve therapeutic adherence in patients with COPD, which can ultimately lead to better health outcomes and quality of life for patients with this chronic disease.

 

SUPPORTIVE SUBMISSION 2- ABSTRACT

Supportive Submission 2- Abstract

ABSTRACT

Purpose: The purpose of this study was to evaluate the efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD). Summary/Results: The authors have chosen an appropriate sample size for the study, with a total of 49 participants, 25 in the control group and 24 in the intervention group. The study used a prospective randomized controlled design that assessed the effect of the intervention on therapeutic adherence. The intervention group was exposed to a combined psychological and geriatric intervention, while the control group was only exposed to standards of care. The outcome measures included self-reported adherence scores, and functional and psychological outcomes. The results of the study indicated significant improvements in therapeutic adherence in the intervention group compared to the control group. Critique: The study was methodologically sound, with a large sample size able to provide valid results. However, the effects of the combined intervention were not measured when each component was administered separately, leaving an underlying question of how effective each intervention is in improving adherence. Implications: The study's findings support the idea that a combined psychological and geriatric intervention should be used to improve therapeutic adherence in COPD patients. Further research is needed to determine the individual components' effects on therapeutic adherence.

 

 

References

Leiva-Fernández J, Leiva-Fernández F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med. 2014 Apr 25; 14:70. doi: 10.1186/1471-2466-14-70. PMID: 24762026; PMCID: PMC4011779.